Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP) - A potential antitumour agent

Journal of Microencapsulation

Volumn 17, Issue 3, 2000, Pages 307-322

  Maclean, D S ^a   Khokhar, A R ^a   Tyle, P ^b   Perez Soler, R ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Aronex Pharmaceuticals   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery; Drug stability; Kinetics; Lipophilic platinum complex; Liposome

Indexed keywords

ANTINEOPLASTIC AGENT; BUFFER; CHLORIDE; CIS BIS NEODECANOATO 1,2 DIAMINOCYCLOHEXANE PLATINUM; CISPLATIN DERIVATIVE; GLYCINE; LIPOSOME; PHOSPHATE; PLATINUM COMPLEX; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DRUG ACTIVATION; DRUG DEGRADATION; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; PH; SUSPENSION; TEMPERATURE; TEMPERATURE DEPENDENCE;

EID: 0034056129     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/026520400288283     Document Type: Article

References (21)

1. CHANEY, S. G., WYRICK, S. D., and TILL, G. K., 1990, In vitro biotransformations of tetrachloro(D,L-trans)-2-diaminocyclohexaneplatinum(IV) (tetraplatinum) in rat plasma. Cancer Research, 50, 4539-4545.
2. HAN, I., KHOKHAR, A. R., and PEREZ-SOLER, R., 1996, Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R, R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R, R-1,2-diaminocyclohexane-platinum (II). Cancer Chemotherapy Pharmacology, 39, 17-24.
3. KHOKHAR, A. R., AL-BAKER, S., BROWN, T., and PEREZ-SOLER, R., 1991, Chemical and biological studies on a series of lipid-soluble (trans-(R,R)-and (S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes. Journal of Medical Chemistry, 34, 325-329.
4. KHOKHAR, A. R., AL-BAKER, S., KRAKOFF, I. H., and PEREZ-SOLER, R., 1989, Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane)-platinum(II) complexes entrapped in liposomes. Cancer Chemotherapy Pharmacology, 23, 219-224.
5. KUOKHAR, A. R., AL-BAKER, S., and PEREZ-SOLER, R., 1992, Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R-and trans-S,S-1,2-diaminocyclohexane)platinum(II) complexes entrapped in liposomes. AntiCancer Drugs, 3, 95-100.
6. LÉVI, F., 1996a, Chronopharmacologie et chronothérapie des cancers. Pathologie Biologie, 44, 631-644 [French].
7. LÉVI, F., 1996b, Chromotherapy for gastrointestinal cancers. Current Opinions in Oncology, 8, 334-341.
8. LUO, F. R., STANKO, J., and CHANEY, S. G., 1998, Pharmacokinetical and neurotoxicological comparison of oxaliplatin, ormaplatin, and their biotransformation products. Proceedings of the American Association for Cancer Research, 39, abstract number 4058.
9. MAULDIN, S. K., GIBBONS, G., WYRICK, S. D., and CHANEY, S. G., 1988a, Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line. Cancer Research, 48, 5136-5144.
10. MAULDIN, S. K., PLESCIA, M., RICHARD, F. A., WYRICK S. D., VOYKSNER, R. D., and CHANEY, S. G., 1988b, Displacement of the bidentate malonate ligand from (D,L-1,2-diaminocyclohexane)malonateplatinum(II) by physiologically important compounds in vitro. Biochemical Pharmacology, 37, 3321-3333.
11. NORTHCOTT, S. E., MARR, J. G. D., SECREAST, S. L., HAN, F., and DEZWAAN, J., 1991, Solution chemistry and analytical characterization of ormaplatin. Journal of Pharmaceutical and Biomedical Analysis, 9, 1009-1018.
12. PEREZ-SOLER, R., and KHOKHAR, A. R., 1992, Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity. Cancer Research, 52, 6341-6347.
13. PEREZ-SOLER, R., FRANCIS, K., AL-BAKER, S., PILKIEWICZ, F., and KHOKHAR, A. R., 1994a, Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use. Journal of Microencapsulation, 11, 41-54.
14. PEREZ-SOLER, R., HAN, I., AL-BAKER, S., and KHOKHAR, A. R., 1994b, Lipophilic platinum complexes entrapped in liposomes: improved stability and preserved antitumor activity with complexes containing linear alkyl crarboxylato leaving groups. Cancer Chemotherapy Pharmacology, 33, 378-384.
15. PEREZ-SOLER, R., KHOKHAR A. R., and LOPEZ-BERESTEIN, G., 1987, Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. Cancer Research, 47, 6462-6466.
16. PEREZ-SOLER, R., LOPEZ-BERESTEIN, G., LAUTERSZTAIN, J. et al. 1990, Phase I clinical and pharmacological study of liposome entrapped cis-bis-neodecanoato-trans-R,R-1,2-diamminocyclohexaneplatinum (II). Cancer Research, 50, 4254-4259.
17. PEREZ-SOLER, R., SHIN, D. M., SIDDIK, Z. H., MURPHY, W. K., HUBER, M., LEE, J. S., KHOKHAR, A. R., and HONG, W. K., 1997, Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clinical Cancer Research, 3, 373-379.
18. PEREZ-SOLER, R., YANG, L. Y., DREWINKO, B., LAUTERSZTAIN, J., and KHOKHAR, A. R., 1988, Increased cytotoxicity and reversal of resistance to cis-diamminedichloroplatinum (II) with entrapment of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) in multilamellar lipid vessels. Cancer Research, 48, 4509-4512.
19. SCRENCI, D., ER, H. M., HAMBLEY, T. W., GALETTIS, P., BROUWER, W., and MCKEAGE, M. J., 1997, Stereoselective peripheral sensory neurotoxicity of diammocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin: British Journal of Cancer, 76, 502-510.
20. SEARS, B., 1983, Hydrophobic platinum compounds and their preparation. European Patent Application 0 113-508.
21. SOULIE, P., RAYMOND, E., BRIENZA, S., and CVITKOVIC, E., 1997. Oxaliplatine: le premier DACH platine en clinique. Bulletin Cancer, 84, 665-673 [French].